Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Reparixin by Dompe Farmaceutici for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Reparixin is under clinical development by Dompe Farmaceutici and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Data Insights
Reparixin by Dompe Farmaceutici for Community Acquired Pneumonia: Likelihood of Approval
Reparixin is under clinical development by Dompe Farmaceutici and currently in Phase III for Community Acquired Pneumonia. According to GlobalData,...